A61P 17 - Drugs for dermatological disorders

Patents for A61P 17 - Drugs for dermatological disorders (106,455)
10/1998
10/28/1998	EP0873111A1 Cosmetic and dermatological sunscreen formulations containing triazine derivatives and alkane carboxylic acids
10/28/1998	EP0701565B1 New prednisolone derivates
10/28/1998	CN1196934A External-use skeleton powder and its prepn. method
10/28/1998	CN1196928A Nanoemulsion based on nonionic amphiphilic lipids and aminated silicones and uses
10/28/1998	CN1040423C Enzymatic resolution of endo bicycle [2.2.1] heptan-2-ol and derived pharmaceutical agents
10/27/1998	US5827883 Topical drug delivery; side effect reduction
10/27/1998	US5827869 Substituted biphenyl isoxazole sulfonamides
10/27/1998	US5827853 Mixture containing product from fermentation by streptomyces for topical application to skin or hair, to improve texture, surface smoothness, firmness
10/27/1998	US5827840 Promotion of wound healing by chemically-modified tetracyclines
10/27/1998	US5827834 Method of using hyaluronic acid or its pharmaceutically acceptable salts for the treatment of disease
10/27/1998	US5827689 Encoding fatty acid biosynthesis (fabd) polypeptides expressed in bacterial genes; vaccines, immunology
10/27/1998	CA1340107C Linear and cyclic analoques of alpha-msh fragments with extraordinary potency
10/22/1998	WO1998046763A1 Methods and compositions for synthesis of long chain polyunsaturated fatty acids
10/22/1998	WO1998046746A1 Extracellular/epidermal growth factor like protein
10/22/1998	WO1998046642A1 MODIFIED TNFα MOLECULES, DNA ENCODING SUCH MODIFIED TNFα MOLECULES AND VACCINES COMPRISING SUCH MODIFIED TNFα MOLECULES AND DNA
10/22/1998	WO1998046606A1 Novel compounds
10/22/1998	WO1998046264A1 Antagonistic anti-avb3 integrin antibodies
10/22/1998	WO1998046217A1 Molecular complex and control-release of alpha hydroxyacids
10/22/1998	WO1998046204A1 Use of at least an irvingia gabonensis extract in a cosmetic and/or pharmaceutical product
10/22/1998	WO1998046201A1 Compositions containing an antifungal and a phospholipid
10/22/1998	WO1998046076A1 Retinoid related molecules for the inhibition of endothelin-1 overproduction in disease
10/22/1998	WO1998036730A3 Compositions for treating acne rosacea
10/22/1998	DE19745792C1 Isolation of wound healing regulatory factors
10/22/1998	DE19716098A1 Fibroblasten mit einem Fremdgen enthaltende Zusammensetzung zur Behandlung von Wunden Fibroblasts with a foreign gene containing composition for the treatment of wounds
10/22/1998	CA2289476A1 Modified tnf.alpha. molecules, dna encoding such modified tnf.alpha. molecules and vaccines comprising such modified tnf.alpha. molecules and dna
10/22/1998	CA2288284A1 Use of at least one irvingia gabonensis extract in a cosmetic and/or pharmaceutical product
10/22/1998	CA2286730A1 Molecular complex and control-release of alpha hydroxyacids
10/22/1998	CA2286351A1 Extracellular/epidermal growth factor like protein
10/22/1998	CA2286078A1 Novel compounds
10/22/1998	CA2285968A1 Methods and compositions for synthesis of long chain polyunsaturated fatty acids
10/22/1998	CA2284726A1 Antagonistic anti-avb3 integrin antibodies
10/21/1998	EP0872247A1 Pharmaceutical formulation
10/21/1998	EP0872244A1 Cosmetic or pharmaceutical composition containing an Andiroba extract
10/21/1998	EP0872243A1 Herb composition, herbal paste and herbal plaster made from the same
10/21/1998	EP0872229A1 Compositions containing an antifungal and a phospholipid
10/21/1998	EP0871730A1 Combination pdgf, kgf, igf and igfbp for wound healing
10/21/1998	EP0871710A1 Recombinant c-proteinase and processes, methods and uses thereof
10/21/1998	EP0871672A1 Human chemokine beta-8, chemokine beta-1 and macrophage inflammatory protein-4
10/21/1998	EP0871663A2 New form of amphiregulin, methods for producing and using the same and compositions comprising the same
10/21/1998	EP0871661A1 Novel protein domain which binds tyrosine phosphorylated proteins
10/21/1998	EP0871647A1 Oligomers which inhibit expression of collagen genes
10/21/1998	EP0871623A1 3-azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists
10/21/1998	EP0871496A1 Arteriovenous and venous graft treatments: methods and compositions
10/21/1998	EP0871489A1 A pharmaceutical composition for administration of an active substance to or through a skin or mucosal surface
10/21/1998	EP0871478A1 Oral tolerance in skin diseases presenting with t-cell mediated inflammation
10/21/1998	EP0871473A1 Pharmaceutical composition containing il-10
10/21/1998	EP0871466A1 Method for the treatment or prevention of eczema/dermatitis
10/21/1998	EP0871439A1 Substituted (aryl, heteroaryl, arylmethyl or heteroarylmethyl) hydroxamic acid compounds
10/21/1998	EP0739351A4 Monomeric diols and phosphate linked oligomers formed therefrom
10/21/1998	EP0710227B1 Vitamin d analogues
10/21/1998	CN1196720A Novel vitamin D analogues
10/21/1998	CN1196243A Powder agent formula for treating acne and seborrhea and preparation method
10/21/1998	CN1040326C Preparation method of imidazopyridine PAF/H1 antagonists
10/21/1998	CN1040321C Pyran-2-ones and 5,6-dihydropyran-2-ones, medicine composition containing them and pharmacy use thereof
10/21/1998	CN1040288C Use of 1,3-dithiole-2-isodipropyl malonate in preparing medicine for accelerating wound healing
10/20/1998	US5824702 Antioxidant behavior, prevents molecular changes leading to skin cancer, prevents protooncogene expression and tumorigenesis
10/20/1998	US5824686 Method of treating androgenic alopecia with 5-alpha reductase inhibitors
10/20/1998	US5824671 Vaginal atrophy, hypogonadism and loss of collagen or connective tissues
10/20/1998	US5824670 17-deoxycorticosteroid-21- O!carboxylic esters, processes for their preparation and pharmaceuticals containing these compounds
10/20/1998	US5824665 Reduction of hair growth
10/20/1998	US5824657 Anticarcinogenic agents, skin disorders and psoriasis
10/20/1998	US5824650 Antiinflammatory agents for skin by applying topically substance p antagonist
10/20/1998	US5824320 Cosmetic or pharmaceutical compositions containing, as active ingredient, mangiferine or its derivatives, in pure form or in plant extracts
10/20/1998	CA2066924C Use of lysine pyrrolidonecarboxylate and(or) arginine pyrrolidonecarboxylate as an antioxidant in pharmaceutical or cosmetic composition
10/20/1998	CA2049729C Methods and compositions containing vitamin d compounds for improvement of skin conditions
10/15/1998	WO1998045712A2 20 human secreted proteins
10/15/1998	WO1998045335A1 N-sulphated hyaluronic acid compounds, derivatives thereof and a process for their preparation
10/15/1998	WO1998045309A1 Novel phosphate compounds and their use as medicaments
10/15/1998	WO1998045268A1 Nicotinamide derivatives
10/15/1998	WO1998044940A1 Use of lactoferin in the treatment of allergen induced disorders
10/15/1998	WO1998044895A2 Cosmetic and dermatological agent with a hard-magnetic particle base
10/15/1998	DE19715478A1 Kosmetisches und dermatologisches Mittel auf Basis von hartmagnetischen Teilchen Cosmetic and dermatological compositions based on hard magnetic particles
10/15/1998	CA2286303A1 20 human secreted proteins
10/15/1998	CA2285960A1 Use of lactoferin in the treatment of allergen induced disorders
10/15/1998	CA2284708A1 Cosmetic and dermatological agent with a hard-magnetic particle base
10/14/1998	EP0870504A2 New compositions comprising biologically active silicon
10/14/1998	EP0870019A2 Cell activation process and reagents therefor
10/14/1998	EP0869955A1 N-acyl-2-substituted-4-(benzimidazolyl- or imidazopyridinyl-substituted residues)-piperidines as tachykinin antagonists
10/14/1998	EP0869946A1 Phenylimidazolidines and use thereof as an antiandrogenic agent
10/14/1998	EP0869945A1 Catechol diethers derivatives useful as pharmaceutical agents
10/14/1998	EP0869810A1 Cyclosporin-containing soft capsule preparations
10/14/1998	EP0869804A1 Supplemented and unsupplemented tissue sealants, methods of their production and use
10/14/1998	EP0869799A1 Method and material for hair therapy
10/14/1998	EP0869797A2 Use of sugar derivatives as antimicrobial, antimycotic and/or antiviral active substances
10/14/1998	EP0869782A2 METHODS OF TREATMENT WITH COMPOUNDS HAVING RAR $g(a)? RECEPTOR SPECIFIC OR SELECTIVE ACTIVITY
10/14/1998	EP0869781A1 Transdermal device for the delivery of flurbiprofen
10/14/1998	EP0869771A1 A cosmetic composition and a method for reducing the ageing processes of skin
10/14/1998	EP0806947A4 Formulations and methods for reducing skin irritation
10/14/1998	EP0684811B1 Use of diglycerine esters against skin impurities
10/14/1998	CN1195991A Preparation of preventing and/or curing trichomadesis
10/14/1998	CN1195980A Composition for topical delivery of active ingredients
10/14/1998	CN1195548A Medicinal liquor for curing hoary hair, flavism and alopecia areata
10/14/1998	CN1195537A Traditional Chinese medicinal preparation for curing psoriasis
10/14/1998	CN1195524A Pharmaceutical formulation
10/14/1998	CA2235057A1 A cosmetic and pharmaceutical formulation containing an andiroba extract
10/13/1998	US5821365 Compounds as enzyme inhibitors for kinases formed by reaction of amine with anhydride group to form indolmaleimide macrocycles
10/13/1998	US5821240 Pyrimido 5,4!-dipyrimidines, pharmaceuticals containing them, their use and processes for the preparation thereof
10/13/1998	US5821231 Treatment of immunoinflammatory conditions
10/13/1998	US5821220 Method of producing concentrated non-buffered solutions of fibronectin
10/13/1998	US5821123 Modified antibody variable domains

1 ... 964 965 966 967 968 969 970 971 972 973 974 975 976 977 978 979 980 981 982 983 984 ... 1065